|   | ![]() Your Search for amplification assay matched 183 Documents (Page 1 of 7). Results Indexed by relevance. |
| 1. |
Direct detection of HIV-1 RNA in clinical specimens, using transcription-mediated amplification. (100%) Abstract: The safety of the blood supply in the United States and elsewhere has been improved in recent years by the implementation of assays that detect HIV-1 antigen during that transient period of time in the infection process when viral titer is high. It is generally accepted that use of nuc ... http://www.aegis.org/aidsline/2000/may/a0050177.html File Name: a0050177.html, Size: 10KB, Last Modified: Sunday, May 28, 2000 at 8:12:04 PM |
| 2. |
Direct, rapid detection of Mycobacterium tuberculosis in clinical specimens using a branched DNA signal amplification assay. (100%) Abstract: We have used a branched DNA (bDNA) signal amplification assay for the direct detection of Mycobacterium tuberculosis DNA in alkaline-treated sputum specimens. The assay relies upon signal amplification using bDNA multimers and a chemiluminescent detection system. Extensive sample preparation is not required. The bacte ... http://www.aegis.org/aidsline/1995/dec/m95c1838.html File Name: m95c1838.html, Size: 9KB, Last Modified: Thursday, December 28, 1995 at 8:12:04 PM |
| 3. |
AEGiS-09IAC: Correlation of HIV-1 plasma RNA and CD4 count as measured by the branched DNA signal amplification assay. (100%) Abstract: <p><b>OBJECTIVE</b>: To quantitate the amount of HIV RNA in patient plasma and correlate copy number with CD4 count and antiretroviral (ARV) therapy as measured by branched DNA (bDNA) signal amplification assay. METHODOLOGY: 1 ml of patient plasma was centrifuged in duplicate using a benchtop microfuge. The resulting ... http://www.aegis.org/conferences/iac/1993/poa320795.html File Name: poa320795.html, Size: 5KB, Last Modified: Sunday, June 06, 1993 at 8:12:04 PM |
| 4. |
[403] ANALYTICAL CHARACTERIZATION OF A SENSITIVE NUCLEIC ACID AMPLIFICATION ASSAY FOR QUANTITATION OF HIV-1 RNA: NUCLISENS HIV-1 QT (70%) Abstract: The new assay was highly specific and demonstrated an increased sensitivity with a broader linear dynamic range compared to other amplification assays for HIV-1 RNA. ... http://www.aegis.org/conferences/iashivpt/2001/403.html File Name: 403.html, Size: 7KB, Last Modified: Monday, July 09, 2001 at 6:29:23 AM |
| 5. |
AEGiS-13IAC: Molecular studies on efficacy of Chinese herbal formula XQ-9302 for AIDS treatment. (70%) Abstract: <p><b>BACKGROUND:</b> To investigate and describe the kinetics in HIV RNA Copies among cases with AIDS before and during the Chinese Herbs XQ-9302 treatment to evaluate the effects in AIDS treatment.</p> <p><b>METHODS:</b> Within the period of 1996-1999, based on the national criteria for AIDS diagnosis, a total of ... http://www.aegis.org/conferences/iac/2000/thpeb5192.html File Name: thpeb5192.html, Size: 7KB, Last Modified: Sunday, July 09, 2000 at 8:12:04 PM |
| 6. |
Rapid diagnosis of tuberculosis in patients infected with HIV. (70%) Abstract: Background: Tuberculosis in HIV-infected patients is highly prevalent in Southern Europe. Rapid diagnosis is important to start specific therapy in these subjects. Objective: To study the clinical usefulness of the amplification assay in the detection of mycobacterium tuberculosis directly in clinical samples of patie ... http://www.aegis.org/aidsline/1997/jan/m9712620.html File Name: m9712620.html, Size: 9KB, Last Modified: Tuesday, January 28, 1997 at 8:12:04 PM |
| 7. |
AEGiS-Glasgow [P117] RAPID DIAGNOSIS OF TUBERCULOSIS IN PATIENTS INFECTED WITH HIV (70%) Abstract: Gen-Probe amplified mycobacterium tuberculosis direct test has the ability to reduce the time required for diagnosis of tuberculosis to one day. Compared to conventional methods, MTD test is a sensitive and specific procedure for the identification of mycobacterium tuberculosis. Rapid and specific therapy in patients i ... http://www.aegis.org/conferences/hiv-glasgow/1996/p117.html File Name: p117.html, Size: 7KB, Last Modified: Sunday, November 03, 1996 at 8:12:04 PM |
| 8. |
AEGiS-11IAC: Rapid diagnosis of tuberculosis in patients infected with HIV. (70%) Abstract: Background: Tuberculosis in HIV-infected patients is highly prevalent in Southern Europe. Rapid diagnosis is important to start specific therapy in these subjects. <p><b>OBJECTIVE</b>: To study the clinical usefulness of the amplification assay in the detection of mycobacterium tuberculosis directly in clinical sampl ... http://www.aegis.org/conferences/iac/1996/tha4074.html File Name: tha4074.html, Size: 6KB, Last Modified: Sunday, July 07, 1996 at 8:12:04 PM |
| 9. |
Monitoring patients on anti-CMV therapies using a quantitative branched DNA (bDNA) signal amplification assay. (70%) Abstract: Objective: Evaluation of changes in quantitation of CMV DNA levels in serial leukocyte specimens. Methods: Cell pellets containing 10(5)-10(6) cells were assayed directly for CMV DNA using a bDNA signal amplification assay. Culture results were also available on ... http://www.aegis.org/aidsline/1995/dec/m95c2826.html File Name: m95c2826.html, Size: 9KB, Last Modified: Thursday, December 28, 1995 at 8:12:04 PM |
| 10. |
AEGiS-10IAC: Quantitation of HIV viral load in PBMCs and plasma using branched DNA (bDNA) signal amplification. (70%) Abstract: <p><b>OBJECTIVE</b>: To evaluate the feasibility of quantitating HIV RNA in Peripheral Blood Mononuclear Cells (PBMCs), and examine the relationship between HIV viral load in these cells with viral load in plasma using a bDNA signal amplification assay.</p> <p><b>METHODS</b>: Plasma and cell samples were obtained fr ... http://www.aegis.org/conferences/iac/1994/580a.html File Name: 580a.html, Size: 6KB, Last Modified: Thursday, August 04, 1994 at 8:12:04 PM |
| 11. |
AEGiS-10IAC: Quantitation of HIV-1 RNA by branched DNA assay during long-term zidovudine therapy. (70%) Abstract: <p><b>OBJECTIVE</b>: To assess HIV-1 RNA levels in plasma by branched DNA (bDNA) assay in patients receiving long-term Zidovudine ( AZT ) therapy and in a placebo group.</p> <p><b>METHODS</b>: 36 initially asymptomatic HIV infected patients enrolled in a controlled trial receiving AZT 1g/day (n = 17) or placebo (n = ... http://www.aegis.org/conferences/iac/1994/577a.html File Name: 577a.html, Size: 6KB, Last Modified: Thursday, August 04, 1994 at 8:12:04 PM |
| 12. |
Direct and quantitative detection of HIV-1 RNA in human plasma with a branched DNA signal amplification assay. (70%) Abstract: AIM: To determine the relative effect of sample matrix on the quantitation of HIV RNA in plasma. METHOD: Two HIV-positive specimens were diluted into five and 10 different HIV-negative plasma samples, respectively. Branched DNA signal amplification technology and reverse-transcriptase polymerase chain reaction were us ... http://www.aegis.org/aidsline/1994/jul/m9470250.html File Name: m9470250.html, Size: 9KB, Last Modified: Thursday, July 28, 1994 at 8:12:04 PM |
| 13. |
Correlation of HIV-1 plasma RNA and CD4 count as measured by the branched DNA signal amplification assay. (70%) Abstract: OBJECTIVE: To quantitate the amount of HIV RNA in patient plasma and correlate copy number with CD4 count and antiretroviral (ARV) therapy as measured by branched DNA (bDNA) signal amplification assay. METHODOLOGY: 1 ml of patient plasma was centrifuged in duplicate using a benchtop microfuge. The resulting virion pel ... http://www.aegis.org/aidsline/1993/nov/m93b4909.html File Name: m93b4909.html, Size: 9KB, Last Modified: Sunday, November 28, 1993 at 8:12:04 PM |
| 14. |
AEGiS-09IAC: Comparison of quantitative bDNA technique with end-point-dilution culture, p24 antigen assay, and RT-PCR quantitation of HIV-1 in plasma. (70%) Abstract: Measuring viral load in plasma is important for understanding AIDS pathogenesis and monitoring treatment efficacy. We compared a novel amplification assay using bDNA technology vs quantitative culture, p24 Ag and RT-PCR for detecting and quantifying plasma viremia. Our results to date showed that the bDNA assay has exc ... http://www.aegis.org/conferences/iac/1993/poa320794.html File Name: poa320794.html, Size: 5KB, Last Modified: Sunday, June 06, 1993 at 8:12:04 PM |
| 15. |
AEGiS-09IAC: Comparison of the branched (bDNA) signal amplification assay with plasma culture (PC) and reverse transcription polymerase chain reaction (RT-PCR) for the detection and quantitation of HIV-1 RNA in plasma. (70%) Abstract: <p><b>OBJECTIVE</b>: To compare HIV-1 RNA levels in 133 plasma samples by the bDNA assay, RT-PCR, and plasma cultures. <p><b>METHODS</b>: Plasma was obtained from 13 patients sequentially over a period of 14-19 weeks, in a blinded AZT + immune modulator study. Frozen specimens were thawed prior to testing with all ... http://www.aegis.org/conferences/iac/1993/pob412480.html File Name: pob412480.html, Size: 6KB, Last Modified: Sunday, June 06, 1993 at 8:12:04 PM |
| 16. |
AEGiS-09IAC: The effect of sample matrix on quantitation of plasma HIV RNA by RT-PCR and by bDNA signal amplification. (70%) Abstract: To determine the relative effect of the sample matrix from different patients on the quantitation of HIV RNA in plasma, HIV-positive plasma collected in EDTA was diluted into ten different HIV-negative plasma samples. Sample dilutions in the linear range were extracted individually, and RT-PCR was performed using the S ... http://www.aegis.org/conferences/iac/1993/pob412483.html File Name: pob412483.html, Size: 6KB, Last Modified: Sunday, June 06, 1993 at 8:12:04 PM |
| 17. |
[5] HIV-specific CD4+ T-cells may contribute to viral persistence in HIV-infected elite controllers (35%) Abstract: The cell-associated viral burden (DNA and RNA) in HIV-infected elite controllers is strongly associated with level of potential target cells (activated CD4+ T-cells and HIV-specific CD4+ T-cells), but not with other host responses. Plasma HIV RNA levels were only associated with the %activated CD8+ T-cells. Collectivel ... http://www.aegis.org/conferences/hivdrw/2009/5.html File Name: 5.html, Size: 7KB, Last Modified: Tuesday, June 09, 2009 at 7:12:04 PM |
| 18. |
AEGiS-15IAC: Analysis of HIV-1 genetic diversity in London and its impact on the performance of viral load assays. (35%) Abstract: BACKGROUND: HIV-1 is characterized by extensive genetic diversity. Within group M, there are 9 subtypes (A-D, F-H, K) and 15 circulating recombinant forms (CRF). In Western Europe, subtype B predominates, but increasing numbers of non-B infections are being observed. In many countries, >20% of new infections are non-su ... http://www.aegis.org/conferences/iac/2004/mopec3419.html File Name: mopec3419.html, Size: 6KB, Last Modified: Monday, May 11, 2009 at 10:19:32 PM |
| 19. |
AEGiS-15IAC: Development of a new kinetic amplification based assay for the detection and quantitation of HIV-1 RNA. (35%) Abstract: BACKGROUND: Human Immunodeficiency Virus-1 (HIV-1) viral load measurement is critical for monitoring disease progression and response to anti-retroviral therapy. The authors have developed a highly sensitive automated kinetic amplification assay that quantifies HIV-1 RNA in human plasma from all group M and O subtypes. ... http://www.aegis.org/conferences/iac/2004/mopeb3167.html File Name: mopeb3167.html, Size: 6KB, Last Modified: Monday, May 11, 2009 at 10:19:30 PM |
| 20. |
AEGiS-13CROI [836]: Risk Factors for Occult Hepatitis B Virus Infection in HIV Patients (35%) Abstract: Among HIV patients, lower CD4 counts, higher HIV viral loads, and the absence of treatment with an anti-HBV ART agent were associated with occult HBV. The prevalence of occult HBV was not greater in HIV+/HCV+ patients compared with HIV+/HCV– patients. The presence of anti-HBs does not rule out occult HBV infection. Tes ... http://www.aegis.org/conferences/croi/2006/836.html File Name: 836.html, Size: 7KB, Last Modified: Sunday, February 05, 2006 at 8:12:04 PM |
| 21. |
[TuPe7.1C21] DETECTION OF MYCOBACTERIUM TUBERCULOSIS IN CEREBROSPINAL FLUID BY MOLECULAR METHODS (35%) Abstract: These preliminary results strongly suggest that the TB2 assay yields excellent predictive positive and negative values for diagnosis of tuberculosis encephalitis. More over, it is also suggested by the accuracy shown by these results that they might be helpful to exclude TB from infections caused by non-tuberculosis pa ... http://www.aegis.org/conferences/iashivpt/2005/tupe7-1c21.html File Name: tupe7-1c21.html, Size: 9KB, Last Modified: Monday, July 25, 2005 at 6:29:23 AM |
| 22. |
AEGiS-15IAC: Polymerase chain reaction (PCR) for Mycobacterium tuberculosis (MTB) DNA in cerebrospinal fluid (CSF) of HIV seropositive patients with focal brain lesions. (35%) Abstract: BACKGROUND: Diagnostic test based on amplification and detection of nucleic acids of MTB directly in clinical samples, would yield results in much shorter time than the conventional techniques, allowing sooner treatments of the MTB-caused life-threatening encephalitis. We report preliminary results using a DNA-amplific ... http://www.aegis.org/conferences/iac/2004/mopeb3183.html File Name: mopeb3183.html, Size: 7KB, Last Modified: Monday, July 12, 2004 at 6:29:23 AM |
| 23. |
AEGiS-15IAC: Pro-Viral HIV-1 DNA PCR test for HIV Diagnosis in Infants. (35%) Abstract: Background;The diagnosis of HIV-1 infection in neonates born to sero positive mothers presents two major dilemmas; the presence of maternal antibodies that preclude the use of serological tests, and the difficulty or impossibility of obtaining large volumes of blood for culture. Objectives;To evaluate a reliable method ... http://www.aegis.org/conferences/iac/2004/b10283.html File Name: b10283.html, Size: 6KB, Last Modified: Monday, July 12, 2004 at 6:29:23 AM |
| 24. |
AEGiS-15IAC: Reversal of mitochondrial DNA and RNA depletion in patients switched to indinavir/ritonavir 800/100mg bid and efavirenz 600mg qd after failing NRTI combination therapy: a prospective, 48 week substudy of HIV-NAT 009. (35%) Abstract: BACKGROUND: Mitochondrial toxicity is associated with nucleoside analogues (NRTIs) and may contribute to lipodystrophy. We studied mitochondrial DNA (mtDNA) and RNA (mtRNA) levels in patients switched to this NRTI sparing regimen after failing NRTIs. Significant increases in limb and visceral fat were previously report ... http://www.aegis.org/conferences/iac/2004/weppb2064.html File Name: weppb2064.html, Size: 7KB, Last Modified: Monday, July 12, 2004 at 6:29:23 AM |
| 25. |
AEGiS-11CROI: Quantification of HIV-1 Subtypes and Clinically Relevant Recombinant Virus Using New Molecular Beacon Viral Load Assay. (35%) Abstract: BACKGROUND: As the prevalence of HIV-1 subtypes and recombinants increases throughout the world, accurate viral load quantification and detection will be paramount for effective management of HIV+ individuals. To this end, a real-time NASBA amplification assay was developed for measurement of HIV-1 RNA levels in plasma ... http://www.aegis.org/conferences/croi/2004/960.html File Name: 960.html, Size: 7KB, Last Modified: Sunday, February 08, 2004 at 8:12:04 PM |
| 26. |
DETECTION OF MICOBACTERIUM TUBERCULOSIS-DNA BY PCR IN CEREBROSPINAL FLUID (CSF): A USEFUL TOOL FOR THERAPEUTIC CHOICES (35%) Abstract: These preliminary results strongly suggest that the TB2 assay yield excellent predictive positive and negative values for diagnosis of tuberculosis encephalitis. More over, it is also suggested by the accuracy shown by these results that they might be helpful to exclude M. tuberculosis from infections caused by NTP. Fi ... http://www.aegis.org/conferences/eacs/2001/posters/107.html File Name: 107.html, Size: 8KB, Last Modified: Monday, December 22, 2003 at 7:09:52 PM |
| 27. |
DETECTION OF MICOBACTERIUM TUBERCULOSIS-DNA BY PCR IN CEREBROSPINAL FLUID (CSF): A USEFUL TOOL FOR THERAPEUTIC CHOICES (35%) Abstract: AEGIS, 8th EUROPEAN CONFERENCE ON CLINIC ASPECTS AND TREATMENT OF HIV - INFECTION. Abstract Form. REFERENCE NUMBER : 155. ECCATH ID : P327. 8th EUROPEAN CONFERENCE ON CLINIC ASPECTS AND TREATMENT OF HIV - INFECTION. Location of research or project (country). Argentina. Thematic Areas:. 8.3. DETECTION OF MICOBACTERIU ... http://www.aegis.org/conferences/eacs/2001/papers/107.html File Name: 107.html, Size: 6KB, Last Modified: Sunday, November 30, 2003 at 1:18:16 AM |
| 28. |
[1232] EVALUATION OF NUCLISENS EASYQ HIV-1 (35%) Abstract: The NucliSens EasyQ HIV-1 is a highthroughput real-time viral load assay that demonstrates broad subtype reactivity and good correlation with two FDA-approved HIV-1 viral load assays. ... http://www.aegis.org/conferences/iashivpt/2003/1232.html File Name: 1232.html, Size: 7KB, Last Modified: Monday, July 14, 2003 at 6:29:23 AM |
| 29. |
[58] TIMING OF MOTHER-TO-CHILD TRANSMISSION OF HIV-1 (MTCT) AND INFANT MORTALITY IN THE FIRST SIX MONTHS OF LIFE IN HARARE, ZIMBABWE (35%) Abstract: In the first 6 months of life, IU and IP/ePP transmission contributed about 25% of the 30.7% MTCT. This is the first study with a large cohort, in the absence of antiretroviral intervention, to define contributions of the three modes of MTCT. Our data, in addition to serving as a historical comparison, may be useful in ... http://www.aegis.org/conferences/iashivpt/2003/58.html File Name: 58.html, Size: 7KB, Last Modified: Monday, July 14, 2003 at 6:29:23 AM |
| 30. |
[678] COMPARISON OF THE NUCLISENS EASYQ HIV-1 ASSAY FOR HIV-1 VIRAL LOAD MEASUREMENT WITH NUCLISENS HIV-1 QT ON ROUTINE CLINICAL SERUM SPECIMENS OF HIV INFECTED PATIENTS (35%) Abstract: Analysis of a set of 223 randomly selected clinical serum samples revealed that NucliSens EasyQ HIV-1 has a comparable performance the reference method NucliSens HIV-1 QT. Samples not quantifiable by either one of the assays are in most cases in the low viral load range. Regarding the workflow it is found that NucliSen ... http://www.aegis.org/conferences/iashivpt/2003/678.html File Name: 678.html, Size: 7KB, Last Modified: Monday, July 14, 2003 at 6:29:23 AM |
|   |
|
|   |
|